Your account is not claimed yet. You can sign up with ORCID to claim your account.

David C Young

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 15

Top Venues

Pediatric pulmonology

Pharmacotherapy

Antimicrobial agents and chemotherapy

University of Utah College of Pharmacy

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Utah College of Pharmacy Jul 1o 1998

United States

Professor of Pharmacotherapy :: Pharmacotherapy

Publications

Paige M Grube, Elizabeth J Beckman, Lauren N Kormelink, David C Young, Jeffrey T Zobell, Zubin N Bhakta, Aric D Schadler, Robert J Kuhn
A decade of change: The evolution of pharmacy services at U.S. cystic fibrosis centers. Pediatric pulmonology (2023)
Venkata Kashyap Yellepeddi, Bryn Lindley, Emi Radetich, Shaun Kumar, Zubin Bhakta, Laurie Leclair, Madison Parrot, David C Young
Population pharmacokinetics and target attainment analysis of vancomycin after intermittent dosing in adults with cystic fibrosis. Antimicrobial agents and chemotherapy (2023)
Lisa T Hong, Kevin James Downes, Alireza FakhriRavari, Jacinda C Abdul-Mutakabbir, Joseph L Kuti, Sarah C J Jorgensen, David C Young, Mohammad H Alshaer, Matteo Bassetti, Robert A Bonomo, Mark Gilchrist, Soo Min Jang, Thomas P Lodise, Jason Alexander Roberts, Thomas Tängdén, Athena Zuppa, Marc H Scheetz
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists. Pharmacotherapy 43 (8) (2023)
Lisa T Hong, Kevin James Downes, Alireza FakhriRavari, Jacinda C Abdul-Mutakabbir, Joseph L Kuti, Sarah C J Jorgensen, David C Young, Mohammad H Alshaer, Matteo Bassetti, Robert A Bonomo, Mark Gilchrist, Soo Min Jang, Thomas P Lodise, Jason Alexander Roberts, Thomas Tängdén, Athena Zuppa, Marc H Scheetz
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary. Pharmacotherapy 43 (8) (2023)
Bryn Lindley, Zubin Bhakta, Laurie Leclair, David C Young
The pharmacokinetics and pharmacodynamics of continuous infusion vancomycin in adult people with cystic fibrosis. Pediatric pulmonology (2023)
Alan Abbinanti, Daniel M Witt, John Saunders, Aubrey E Jones, David C Young
Venous thromboembolism management in people with cystic fibrosis. Pediatric pulmonology (2023)
Cameron J McKinzie, Charissa W Kam, Jeffrey T Zobell, David C Young
Effective pharmacy provider handoff communication for transition of patient care in CF. Pediatric pulmonology (2023)
Bryn Lindley, Zubin Bhakta, Kristine Gray, Alexandre Watanabe, Laurie Leclair, David C Young
Pharmacokinetics of intermittent dosed intravenous vancomycin in adult persons with cystic fibrosis. Pediatric pulmonology 57 (11) (2022)
Jeffrey T Zobell, Justin Moss, Stephanie Heuser, Lynda Roe, David C Young
Understanding the expanding role of pharmacy services in outpatient cystic fibrosis care. Pediatric pulmonology 56 (6) (2021)
Quovadis J Epps, Kevin L Epps, David C Young, Jeffrey T Zobell
State of the art in cystic fibrosis pharmacology optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: III. Executive summary. Pediatric pulmonology 56 (7) (2021)
Jonathan J Grant, Erin J McDade, Jeffrey T Zobell, David C Young
The indispensable role of pharmacy services and medication therapy management in cystic fibrosis. Pediatric pulmonology (2021)
Quovadis J Epps, Kevin L Epps, Jeffrey T Zobell, David C Young
Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations:  II. Therapies for allergic bronchopulmonary aspergillosis. Pediatric pulmonology 55 (12) (2020)
Quovadis J Epps, Kevin L Epps, David C Young, Jeffrey T Zobell
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics. Pediatric pulmonology 55 (1) (2019)
David C Young, Elizabeth J Beckman, Jeffrey T Zobell, Lauren Kormelink, Karen Homa, Kathryn A Sabadosa, Jamshed Kanga, Michael Anstead, Robert Kuhn
Patients and families experience with pharmacist care at cystic fibrosis foundation accredited clinics. Pediatric pulmonology 54 (8) (2019)
Morgan T Ratté, Aubrey E Jones, Daniel M Witt, David C Young
Survey of current treatment practices for venous thromboembolism in patients with cystic fibrosis. Pediatric pulmonology 55 (1) (2019)

David C Young.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David C Young